Literature DB >> 14734861

Reflections on shunt infection.

Paul M Kanev1, Jonas M Sheehan.   

Abstract

The placement and revision of ventriculoperitoneal (VP) shunts remains a mainstay in the surgical treatment of hydrocephalus. While the North American infection rate averages nearly 8-10%, published infection rates for VP shunt infection below 1% have been reported. We retrospectively reviewed shunt operations by a single surgeon over 62 months to analyze the infection rate. In 62 months, we performed 526 shunt placements or revisions in patients up to 18 years of age. There were 7 shunt infections (1.33%). In 5 cases, the organism was Staphylococcus epidermidis, and a single shunt each was infected with Haemophilus influenzae and Staphylococcus aureus. Each infection was treated with external ventriculostomy drainage and intravenous antibiotics. The new shunt was placed at a new incision site after at least 5 days of sterile spinal fluid cultures. The mean follow-up among these patients after shunt insertion was 25 months. VP shunting remains the most common operation for hydrocephalus. Infections are linked with seizures, higher future risks of shunt infection and malfunction, and reduced IQ and school performance. Our infection rate during 62 months was limited to 1.33%. Uniform surgical technique, limited hardware and skin edge manipulation and double gloving may be important factors in limiting shunt infections. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14734861     DOI: 10.1159/000075255

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  22 in total

1.  Ventriculoperitoneal shunt infection after an insect sting.

Authors:  Mehmet Yaman; Kaya Suer; Asli Kaptanoglu; Ferhat Harman; Erkan Kaptanoglu
Journal:  Childs Nerv Syst       Date:  2012-02-10       Impact factor: 1.475

2.  Third ventriculostomy vs ventriculoperitoneal shunt in pediatric obstructive hydrocephalus: results from a Swiss series and literature review.

Authors:  Sandrine de Ribaupierre; B Rilliet; O Vernet; L Regli; J-G Villemure
Journal:  Childs Nerv Syst       Date:  2007-01-17       Impact factor: 1.475

3.  Few Patient, Treatment, and Diagnostic or Microbiological Factors, Except Complications and Intermittent Negative Cerebrospinal Fluid (CSF) Cultures During First CSF Shunt Infection, Are Associated With Reinfection.

Authors:  Tamara D Simon; Nicole Mayer-Hamblett; Kathryn B Whitlock; Marcie Langley; John R W Kestle; Jay Riva-Cambrin; Margaret Rosenfeld; Emily A Thorell
Journal:  J Pediatric Infect Dis Soc       Date:  2013-08-26       Impact factor: 3.164

4.  Antibiotic-impregnated catheters reduce ventriculoperitoneal shunt infection rate in high-risk newborns and infants.

Authors:  Giovanni Raffa; Lucia Marseglia; Eloisa Gitto; Antonino Germanò
Journal:  Childs Nerv Syst       Date:  2015-03-28       Impact factor: 1.475

5.  Early ventriculoperitoneal shunt infection.

Authors:  Emilio Pintor; Maria Jose Gutierrez; Pedro Gargantilla; Benjamín Herreros
Journal:  Infection       Date:  2016-04-18       Impact factor: 3.553

6.  Cutibacterium acnes Central Nervous System Catheter Infection Induces Long-Term Changes in the Cerebrospinal Fluid Proteome.

Authors:  Matthew Beaver; Dragana Lagundzin; Ishwor Thapa; Junghyae Lee; Hesham Ali; Tammy Kielian; Gwenn L Skar
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

7.  A randomised control trial on the use of topical methicillin in reducing post-operative ventriculoperitoneal shunt infection.

Authors:  Sharon Casilda Theophilus; Johari Siregar Adnan
Journal:  Malays J Med Sci       Date:  2011-01

8.  Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy E Gove; Nicole Mayer-Hamblett; Samuel R Browd; D Douglas Cochrane; Richard Holubkov; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; W Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2018-02-02       Impact factor: 2.375

9.  Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy Gove; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; Nicole Mayer-Hamblett
Journal:  J Pediatr       Date:  2016-09-28       Impact factor: 4.406

Review 10.  Implantable Device-Related Infection.

Authors:  J Scott VanEpps; John G Younger
Journal:  Shock       Date:  2016-12       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.